Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$80.76 USD

80.76
1,176,838

+0.38 (0.47%)

Updated Aug 29, 2024 04:00 PM ET

After-Market: $80.75 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

BioScrip (BIOS) Q1 Loss Narrower than Expected, Sales Miss

BioScrip, Inc. (BIOS) reported net loss from continuing operations of $19.4 million or a loss of 18 cents per share in the first quarter of 2017 compared with net loss of $9.5 million or a loss of 17 cents a year ago.

    Allscripts (MDRX) Beats on Q1 Earnings, Revenues In Line

    Allscripts Healthcare Solutions, Inc. (MDRX) reported first-quarter 2017 earnings of 10 cents per share, beating the Zacks Consensus Estimate by a penny.

      Omnicell (OMCL) Q1 Loss Narrower than Expected, Revenues Lag

      Omnicell, Inc. (OMCL) reported a loss per share of 29 cents in first-quarter 2017, reflecting a deterioration from the year-ago loss of a penny.

        Wright Medical (WMGI) Posts Wider-than-Expected Loss in Q1

        Wright Medical Group N.V. (WMGI) reported adjusted loss of 9 cents per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 8 cents.

          PerkinElmer (PKI) Tops Q1 Earnings Estimates, FY17 View Up

          PerkinElmer Inc (PKI) reported first-quarter 2017 adjusted earnings of 55 cents per share, marginally beating the Zacks Consensus Estimate by a penny.

            athenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1

            athenahealth Inc. (ATHN) reported adjusted earnings of 10 cents per share in the first quarter of fiscal 2017.

              AmerisourceBergen (ABC) Beats on Q2 Earnings, Lags Revenues

              AmerisourceBergen Corporation (ABC) posted adjusted earnings of $1.77 per share in the second quarter of fiscal 2017, beating the Zacks Consensus Estimate of $1.71 and increasing 5.4% on a year-over-year basis.

                Cardiovascular Systems (CSII) Swings to Earnings in Q3

                Cardiovascular Systems, Inc. (CSII) reported adjusted earnings per share of 3 cents in third-quarter fiscal 2017, reflecting a massive improvement from the year-ago quarter's adjusted loss of 47 cents.

                  Bruker (BRKR) Q1 Earnings Meet, Revenues Beat Estimates

                  Bruker Corporation (BRKR) reported adjusted earnings per share (EPS) of 19 cents in the first quarter of 2017, lower than the year-ago figure by 9.5%.

                    DaVita (DVA) Earnings Miss Estimates, Revenues Beat in Q1

                    DaVita Inc. (DVA) reported first-quarter 2017 adjusted operating earnings of 79 cents per share that missed the Zacks Consensus Estimate of 82 cents.

                      QIAGEN (QGEN) Beats Q1 Earnings Estimates, Retains View

                      QIAGEN N.V. (QGEN) reported first-quarter 2017 adjusted earnings per share (considering restructuring expenses as one time item) of 22 cents, up 15.8% year over year.

                        DexCom (DXCM) Q1 Loss Narrower than Expected, Revenues Miss

                        DexCom Inc. (DXCM) reported a loss of 49 cents per share in the first quarter of 2017, narrower than the Zacks Consensus Estimate of a loss of 55 cents.

                          Myriad Genetics (MYGN) Tops Q3 Earnings & Sales, Tweaks View

                          Myriad Genetics Inc. (MYGN) reported adjusted earnings per share (EPS) of 27 cents in the third quarter of fiscal 2017, down 34% year over year.

                            Amedisys (AMED) Beats on Q1 Earnings, Revenues Meet Mark

                            Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 47 cents per share in the first quarter of 2017, up 42.4% year over year.

                              CVS Health (CVS) Q1 Earnings Beat Estimates, Decrease Y/Y

                              CVS Health Corporation (CVS) reported first-quarter 2017 adjusted earnings per share (EPS) of $1.17, down 0.8% year over year.

                                Ecolab (ECL) Q1 Earnings Miss Estimates, Revenues In Line

                                Ecolab Inc. (ECL) reported first-quarter 2017 adjusted earnings (excluding special gains, charges and tax items) of 80 cents per share, which missed the Zacks Consensus Estimate of 81 cents.

                                  Becton, Dickinson (BDX) Q2 Earnings Beat, Increase Y/Y

                                  Becton, Dickinson and Company (BDX), popularly known as BD, reported second-quarter fiscal 2017 earnings of $2.30 per share, which beat the Zacks Consensus Estimate of $2.23 and increased 5.5% on a year-over-year basis.

                                    Luminex (LMNX) Tops Q1 Earnings, Revenue Guidance Raised

                                    Luminex Corporation (LMNX) reported earnings of 27 cents per share in the first quarter of 2017, surpassing the Zacks Consensus Estimate of adjusted earnings of 8 cents per share by a massive 237.5%.

                                      Cardinal Health (CAH) Q3 Earnings Beat Estimates, Rise Y/Y

                                      Cardinal Health Inc. (CAH) reported third-quarter fiscal 2017 adjusted earnings of $1.53 per share, which beat the Zacks Consensus Estimate of $1.46 and increased 7% on a year-over-year basis.

                                        Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2

                                        Hill-Rom Holdings, Inc. (HRC) reported second-quarter fiscal 2017 adjusted earnings per share (EPS) of 88 cents, up 23.9% from the year-ago quarter.

                                          Accuray (ARAY) Incurs Loss in Q3, Revenues Miss Estimates

                                          Accuray Inc.(ARAY) reported a loss of 6 cents per share in the third quarter of fiscal 2017, comparing unfavorably with the Zacks Consensus Estimate of earnings of a penny.

                                            Is a Surprise in Store for Hologic (HOLX) in Q2 Earnings?

                                            Hologic Inc. (HOLX) is slated to report second-quarter fiscal 2017 financial results on May 10, after the closing bell.

                                              Align Technology (ALGN) Beats on Q1 Earnings and Revenues

                                              Align Technology Inc. (ALGN) reported adjusted earnings per share (EPS) of 85 cents in the first quarter of 2017, up 70% from 50 cents posted in the year-ago quarter.

                                                athenahealth (ATHN) Misses on Earnings & Revenues in Q1

                                                athenahealth Inc. (ATHN) reported adjusted earnings of 10 cents per share in the first quarter of fiscal 2017, which missed the Zacks Consensus Estimate by a penny.

                                                  Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1

                                                  Chemed Corp.'s (CHE) first-quarter 2017 adjusted earnings per share (EPS) (considering stock-based compensation expense and related tax benefit as a regular one) were $1.92, as compared to the year-ago adjusted EPS figure of $1.52, up 26.3% year over year.